Weinstein Ib
Impact in
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
-
- DNA and Nucleic Acid Chemistry 5
- Biological Activity of Diterpenoids and Biflavonoids 4
- Bioactive Natural Diterpenoids Research 2
- Protein Kinase Regulation and GTPase Signaling 2
- Oncology 12
- Cancer-related Molecular Pathways 6
- Cancer Treatment and Pharmacology 4
- Co-authors
- Dezider Grünberger (3 shared papers)Nadir Arber (3 shared papers)Thomas R. Sutter (2 shared papers)Doriano Fabbro (1 shared paper)Peter R. Holt (3 shared papers)Melissa D. Begg (1 shared paper)Yu Zhang (1 shared paper)Hanina Hibshoosh (1 shared paper)
- Journals
- Gastroenterology (3 papers)British Journal of Cancer (1 paper)Molecular Pharmacology (1 paper)PubMed (46 papers)
- Partner nations
- United StatesIsraelSouth Korea
In The Last Decade
Weinstein Ib
52 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 110
- Cancer Research 401
- Oncology 610
- Molecular Biology 1.3k
- Cell Biology 159
- Biotechnology 76
Countries citing papers authored by Weinstein Ib
This map shows the geographic impact of Weinstein Ib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weinstein Ib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weinstein Ib more than expected).
Fields of papers citing papers by Weinstein Ib
This network shows the impact of papers produced by Weinstein Ib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weinstein Ib. The network helps show where Weinstein Ib may publish in the future.
Co-authors
The 25 scholars most cited alongside Weinstein Ib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 281 | |
| 2 | The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. | 1993 | 210 |
| 3 | Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. | 1995 | 134 |
| 4 | Altered levels of protein kinase C and Ca2+-dependent protein kinases in human colon carcinomas. | 1987 | 116 |
| 5 | Differential excision from DNA of the C-8 and N2 guanosine adducts of N-acetyl-2-aminofluorene by single strand-specific endonucleases. | 1977 | 98 |
| 6 | Effect of N-2-acetylaminofluorene modification on the conformation of nucleic acids. | 1974 | 98 |
| 7 | Expression of cyclins D1 and E in human colon adenocarcinomas. | 1997 | 70 |
| 8 | Linking protein kinase C to the cell cycle: ectopic expression of PKC eta in NIH3T3 cells alters the expression of cyclins and Cdk inhibitors and induces adipogenesis. | 1996 | 65 |
| 9 | Ultraviolet light induces the expression of oncogenes in rat fibroblast and human keratinocyte cells. | 1988 | 63 |
| 10 | Disturbances in growth control and gene expression in a C3H/10T1/2 cell line that stably overproduces protein kinase C. | 1989 | 59 |
| 11 | Binding of [3H]benzo(a)pyrene to natural and synthetic nucleic acids in a subcellular microsomal system. | 1975 | 52 |
| 12 | Expression of retroviral sequences and oncogenes in rat liver tumors induced by diethylnitrosamine. | 1987 | 49 |
| 13 | Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation. | 1978 | 48 |
| 14 | Induction of chemotaxis in mouse peritoneal macrophages by phorbol ester tumor promoters. | 1981 | 46 |
| 15 | 1 alpha,25-dihydroxyvitamin D3-induced regulation of protein kinase C gene expression during HL-60 cell differentiation. | 1991 | 44 |
| 16 | Modulation of phagocytosis by tumor promoters and epidermal growth factor in normal and transformed macrophages. | 1980 | 43 |
| 17 | The role of protein kinase C in growth control and the concept of carcinogenesis as a progressive disorder in signal transduction. | 1990 | 38 |
| 18 | Structure-activity studies on the mechanism of action of miracil D. | 1968 | 38 |
| 19 | Effect of N-2-acetylaminofluorene modification on the structure and template activity of DNA and reconstituted chromatin. | 1977 | 37 |
| 20 | 1965 | 36 |
About Weinstein Ib
Weinstein Ib is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Pharmacology, having authored 52 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Carcinogens and Genotoxicity Assessment (5 papers), DNA and Nucleic Acid Chemistry (5 papers), Biological Activity of Diterpenoids and Biflavonoids (4 papers), Cancer Treatment and Pharmacology (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Bioactive Natural Diterpenoids Research (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). The work is most often cited by research in Cancer Research (401 citations), Oncology (610 citations), Molecular Biology (1.3k citations), Cell Biology (159 citations) and Biotechnology (76 citations). Weinstein Ib has collaborated with scholars based in United States, Israel and South Korea. Frequent co-authors include Dezider Grünberger, Nadir Arber, Thomas R. Sutter, Doriano Fabbro, Peter R. Holt, Melissa D. Begg, Yu Zhang, Hanina Hibshoosh, Silu Wang and Ira Schieren. Their work appears in journals such as Gastroenterology, British Journal of Cancer, Molecular Pharmacology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.